Printer Friendly
The Free Library
14,679,167 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Xcyte Therapies, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock.


SEATTLE Seattle (sēăt`əl), city (1990 pop. 516,259), seat of King co., W Wash., built on seven hills, between Elliott Bay of Puget Sound and Lake Washington; inc. 1869.  -- Xcyte Therapies, Inc. ("Xcyte", the "Company") (Nasdaq:XCYT)(Nasdaq:XCYTP) announced today that the Company's Board of Directors has declared a quarterly dividend in the amount of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock Convertible exchangeable preferred stock

Convertible preferred stock that may be exchanged, at the issuer's option, into convertible bonds that have the same conversion features as the convertible preferred stock.
 (the "Preferred Stock Stock shares that have preferential rights to dividends or to amounts distributable on liquidation, or to both, ahead of common shareholders.

Preferred stock is given preference over common stock. Holders of preferred stock receive dividends at a fixed annual rate.
") in accordance Accordance is Bible Study Software for Macintosh developed by OakTree Software, Inc.[]

As well as a standalone program, it is the base software packaged by Zondervan in their Bible Study suites for Macintosh.
 with the terms thereof. Xcyte issued 2,990,000 shares of the Preferred Stock in November 2004. As of January 5, 2006, approximately 943,000 shares of the Preferred Stock have been converted to the Company's common stock. The dividend on the Preferred Stock will be paid on February 1, 2006 to the holders of record as of the close of business on January 20, 2006.

Xcyte(R) and Xcyte Therapies(TM) are trademarks of Xcyte Therapies, Inc.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:Xcyte Therapies, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock.
Publication:Business Wire
Geographic Code:1USA
Date:Jan 9, 2006
Words:122
Previous Article:Symmetricom, Inc. Fiscal 2006 Second Quarter Financial Results Conference Call Scheduled for Jan. 26.
Next Article:Pediatrix to Present at JP Morgan Healthcare Conference.
Topics:



Related Articles
American Equity sets $67.8 million stock issue. (American Equity Trust Inc.)
Marchex Announces Regular Quarterly Dividend for 4.75% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. Announces Third Quarter 2005 Financial Results.
Xcyte Receives Notice of Non-Compliance with Nasdaq Continued Listing Standard.
Marchex Announces Regular Quarterly Dividend for 4.75% Convertible Exchangeable Preferred Stock.
Xcyte Therapies, Inc. to Mail Proxy for Proposed Transaction and Asset Sale; NASDAQ Grants Listing Continuation.
Xcyte Therapies, Inc. Announces Full-Year and Fourth Quarter 2005 Financial Results.
Xcyte Therapies, Inc. Announces One-for-Ten Reverse Split of Common Stock.
Marchex Announces Regular Quarterly Dividend for 4.75% Convertible Exchangeable Preferred Stock.
Marchex Announces Regular Quarterly Dividend for 4.75% Convertible Exchangeable Preferred Stock.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles